文献速递功能神经外科

深部脑刺激治疗神经性厌食症与肥胖的有效性:系统综述

Effectiveness of Deep Brain Stimulation in Treatment of Anorexia Nervosa and Obesity: A Systematic Review.
PubMed 文献 · World Neurosurg · 2022-10-01

该综述检索了PubMed、Scopus和Web of Science(2022年6月7日),纳入23项研究(17项厌食症、5项肥胖),共131例患者。厌食症患者DBS最常见靶点为胼胝体下扣带回,平均17.1个月内BMI总体增加24.82%;肥胖患者最常见靶点为下丘脑外侧,平均17.2个月内BMI小幅下降3.97%。作者认为DBS对难治性厌食症似乎有前景,但肥胖症需进一步前瞻性研究。

要点

  • 厌食症DBS最常见靶点为胼胝体下扣带回,其次为伏隔核,平均17.1个月BMI增加24.82%。
  • 肥胖症DBS最常见靶点为下丘脑外侧,其次为伏隔核,平均17.2个月BMI下降3.97%。
  • 厌食症队列常合并重性抑郁障碍、强迫症和焦虑等精神共病。

核心结论

  • DBS似乎为难治性厌食症提供了一个有前景的解决方案,但仍需额外的前瞻性研究来确认其对肥胖症治疗的同样有效性。

研究设计与样本

  • 系统综述,检索PubMed、Scopus和Web of Science数据库,检索日期为2022年6月7日。
  • 纳入标准:涉及DBS、治疗神经性厌食症或肥胖症、以体重指数(BMI)为主要结局变量的研究;病例报告、回顾性队列研究和随机对照试验均可纳入。
  • 排除标准:荟萃分析或系统综述;描述除厌食症或肥胖症以外疾病的研究。
  • 初始检索返回999篇文章,筛选后纳入23项研究进行数据提取,包括8篇病例报告、13篇病例系列和1项病例对照研究。
  • 纳入研究依据纽卡斯尔-渥太华量表标准进行质量评估。

主要发现

  • 共纳入23篇文章(17项厌食症、5项肥胖症),合计131例患者,其中118例属于厌食症队列。
  • 厌食症患者DBS最常见靶点为胼胝体下扣带回,其次为伏隔核,平均17.1个月内BMI总体增加24.82%。
  • 肥胖症患者DBS最常见靶点为下丘脑外侧,其次为伏隔核,平均17.2个月内BMI小幅下降3.97%。
  • 厌食症队列中精神共病(重性抑郁障碍、强迫症和焦虑)常见。
  • 肥胖症队列数据不足以报告其他精神共病或计算从诊断到治疗的时间。

局限性

  • 主要局限性包括明显缺乏DBS治疗肥胖症的数据,以及缺乏评估DBS与对照治疗相比疗效的队列研究。
  • 这些局限性无法在当前综述中解决,但本研究可能激励未来试验以更可控的方式评估DBS在食欲障碍患者中的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anorexia nervosa and obesity are common appetite disorders, which may be life threatening if not treated and often coincide with psychiatric disorders. We sought to investigate whether deep brain stimulation (DBS) of specific regions within the brain could aid in the treatment of these disorders. This review aims to organize the literature regarding the feasibility of DBS via clinical outcomes and synthesize the data on patient demographics and electrode parameters for future optimization. METHODS: PubMed, Scopus, and Web of Science databases were all queried on 7 June 2022 to identify studies reporting the effect of DBS in treatment of either anorexia nervosa or obesity. We included studies involving 1) DBS, 2) treatment of anorexia nervosa or obesity, and 3) body mass index (BMI) as the primary outcome variable. Case reports, retrospective cohort studies, and randomized controlled trials were all eligible for inclusion. Exclusion of articles was based on the following criteria: 1) meta-analyses or systematic reviews or 2) describes diseases other than only anorexia or obesity. Screening of the 999 articles returned by an initial search yielded 23 studies for inclusion and further data extraction. Qualitative assessment of included studies was subsequently conducted in accordance with Newcastle-Ottawa Scale criteria. RESULTS: We included 23 articles (17 anorexia, 5 obesity) that met our inclusion and exclusion criteria, which included 8 case reports, 13 case series, and 1 case-control study. Our primary variables of interest were location of DBS, change in BMI after intervention, electrode parameters, and psychiatric comorbidities. A total of 131 patients were included and analyzed, 118 of those belonging in the anorexia cohort. For patients with anorexia, we found that the most common place for DBS was the subcallosal cingulate followed by the nucleus accumbens, resulting in an overall increase in BMI by 24.82% over the span of a mean 17.1 months. Psychiatric comorbidities (major depressive disorder, obsessive-compulsive disorder, and anxiety) were common in the anorexia cohort. For patients with obesity, DBS was most common in the lateral hypothalamus followed by the nucleus accumbens, resulting in a small decrease in BMI by 3.97% over a mean 17.2 months. Data were insufficient for this cohort to report on additional psychiatric comorbidities or calculate the duration from diagnosis to treatment. CONCLUSIONS: DBS seems to be a promising solution in addressing treatment-refractory anorexia, but additional prospective studies are still needed to confirm this same usefulness for the treatment of obesity. Primary limitations included the apparent lack of data on DBS for obesity as well as the dearth of cohort studies assessing efficacy of DBS compared with control treatments. Although these limitations could not be addressed in the current review, this study may incentivize future trials to assess DBS in patients with appetite disorders in a more controlled fashion.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hsu TI, Nguyen A, Gupta N, et al. Effectiveness of Deep Brain Stimulation in Treatment of Anorexia Nervosa and Obesity: A Systematic Review. World Neurosurg. 2022. PMID: 36191890. doi:10.1016/j.wneu.2022.09.114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。